MelanoDB: A dataset of clinical and molecular features of patients with advanced melanoma treated with MAPK inhibitors
Abstract MAPK inhibitors (MAPKi) have revolutionized the treatment of patients with advanced melanoma. However, primary and acquired resistance mechanisms limit their efficacy. Predicting MAPKi response from the tumor baseline features remains challenging due to the limited size of patient cohorts....
Saved in:
| Main Authors: | Sarah Dandou, Julie A. Vendrell, Jérôme Solassol, Baptiste Louveau, Céleste Lebbé, Samia Mourah, Florian Rambow, Eric Richard, Stanislas Du Manoir, Alain Mangé, Peter J. Coopman, Ovidiu Radulescu, Romain M. Larive |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Data |
| Online Access: | https://doi.org/10.1038/s41597-025-05291-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitors
by: Julie Delyon, et al.
Published: (2024-11-01) -
Improved prediction of MAPKi response duration in melanoma patients using genomic data and machine learning
by: Sarah Dandou, et al.
Published: (2025-07-01) -
MelanoDet: Multimodal Imaging System for Screening and Analysis of Cutaneous Melanoma
by: Alina Elena Sultana, et al.
Published: (2025-01-01) -
ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors
by: Geoffrey Richard, et al.
Published: (2016-09-01) -
EFEK IMMUNOTOKSIK LOGAM BERAT MERKURI KLORIDA (HgCl2) TERHADAP PERUBAHAN UKURAN MELANO-MAKROFAG GINJAL IKAN MAS (Cyprinus carpio)
by: Lailatul Mubarokah, et al.
Published: (2019-01-01)